Spermidine, an autophagy inducer, as a therapeutic strategy in neurological disorders I Ghosh, R Sankhe, J Mudgal, D Arora, M Nampoothiri Neuropeptides 83, 102083, 2020 | 42 | 2020 |
Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study R Sankhe, E Rathi, S Manandhar, A Kumar, SRK Pai, SG Kini, A Kishore Journal of molecular structure 1224, 129073, 2021 | 26 | 2021 |
Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy SK Reddy, AR Ballal, S Shailaja, RN Seetharam, CH Raghu, R Sankhe, ... Theranostics 13 (7), 2241, 2023 | 14 | 2023 |
Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies S Moorkoth, NS Prathyusha, S Manandhar, Y Xue, R Sankhe, KSR Pai, ... Pharmacological Reports 73, 1273-1286, 2021 | 14 | 2021 |
Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer’s disease S Manandhar, R Sankhe, K Priya, G Hari, H Kumar B, CH Mehta, ... Molecular Diversity 26 (5), 2793-2811, 2022 | 13 | 2022 |
Tumour suppression through modulation of neprilysin signaling: A comprehensive review R Sankhe, SRK Pai, A Kishore European Journal of Pharmacology 891, 173727, 2021 | 13 | 2021 |
Beta-caryophyllene, a CB2R selective agonist, protects against cognitive impairment caused by neuro-inflammation and not in dementia due to ageing induced by mitochondrial … U Kanojia, SG Chaturbhuj, R Sankhe, M Das, R Surubhotla, N Krishnadas, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2021 | 7 | 2021 |
Neprilysin, the kidney brush border neutral proteinase: a possible potential target for ischemic renal injury R Sankhe, M Kinra, J Mudgal, D Arora, M Nampoothiri Toxicology Mechanisms and Methods 30 (2), 88-99, 2020 | 7 | 2020 |
Dehydrozingerone promotes healing of diabetic foot ulcers: a molecular insight F Begum, S Manandhar, G Kumar, R Keni, R Sankhe, PC Gurram, ... Journal of Cell Communication and Signaling 17 (3), 673-688, 2023 | 3 | 2023 |
In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of novel coronavirus (COVID-19) and SARS-CoV K Chunduru, R Sankhe, F Begum, N Sodum, N Kumar, A Kishore, ... Medicinal Chemistry 17 (4), 380-395, 2021 | 3 | 2021 |
New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation R Sankhe, A Gopinathan, K Nandakumar, A Kishore Journal of Neuroimmune Pharmacology 19 (1), 1-26, 2024 | 2 | 2024 |
Amelioration of high-fat diet (HFD)+ CCl4 induced NASH/NAFLD in CF-1 mice by activation of SIRT-1 using cinnamoyl sulfonamide hydroxamate derivatives: in-silico molecular … N Sodum, V Rao, SP Cheruku, G Kumar, R Sankhe, A Kishore, N Kumar, ... 3 Biotech 12 (7), 147, 2022 | 2 | 2022 |
Spermidine, an autophagy inducer, as a therapeutic antiaging strategy M Nampoothiri, KK Kolathur, R Sankhe, S Satarker Emerging anti-aging strategies, 135-153, 2023 | 1 | 2023 |
Structure based virtual docking and molecular dynamics guided identification of potential phytoconstituents from traditionally used female antifertility plant K Priya, S Manandhar, R Sankhe, MM Setty, UV Babu, SR Pai Pharmaceutical Sciences 28 (2), 285-294, 2021 | 1 | 2021 |
An in silico drug repurposing approach to identify HDAC1 inhibitors against glioblastoma A Gopinathan, R Sankhe, E Rathi, T Kodi, R Upadhya, KSR Pai, ... Journal of Biomolecular Structure and Dynamics, 1-14, 2024 | | 2024 |
Clinical protocols for nanopharmacokinetics assessment S Manandhar, R Sankhe, BH Kumar, KSR Pai Nano-Pharmacokinetics and Theranostics, 193-220, 2021 | | 2021 |
Identification of Probable Plant-based Oral Contraceptives from Cissampelos Pareira using Virtual Screening and Molecular Dynamics Simulation Studies K Priya, R Sankhe, S Manandhar, MM Setty, S Pai Proceedings of International Conference on Drug Discovery (ICDD), 2020 | | 2020 |
Development of New Neprilysin Inhibitor as a Modulator of Chronic Kidney and Heart Disease Using In Silico Drug Repurposing Approach R Sankhe, A Kumar, E Rathi, A Kishore Conference on Drug Design and Discovery Technologies 355, 45, 2019 | | 2019 |
Ketogenic Diet with Oxyresveratrol and Zinc Inhibits Glioblastoma and Restores Memory Function and Motor Coordination TV Gujaran, V Balaji E, R Sankhe, P Bakthavatchalam, HS Dsouza, S Pai Runali and Bakthavatchalam, Pugazhandhi and Dsouza, Herman Sunil and Pai, K …, 0 | | |